These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Serum antibody responses after intradermal vaccination against influenza. Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713 [TBL] [Abstract][Full Text] [Related]
24. Dose sparing with intradermal injection of influenza vaccine. Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714 [TBL] [Abstract][Full Text] [Related]
25. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
26. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Müller D; Szucs TD Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of influenza by use of intradermal vaccination]. Kyncl J Cas Lek Cesk; 2009; 148(5):191-3. PubMed ID: 19642311 [TBL] [Abstract][Full Text] [Related]
28. Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004. Müller D; Wutzler P; Szucs TD Med Klin (Munich); 2005 Jan; 100(1):6-13. PubMed ID: 15654537 [TBL] [Abstract][Full Text] [Related]
29. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987 [TBL] [Abstract][Full Text] [Related]
33. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Orellano PW; Reynoso JI; Carlino O; Uez O Vaccine; 2010 Jul; 28(32):5288-91. PubMed ID: 20541580 [TBL] [Abstract][Full Text] [Related]
34. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit. Shah SI; Caprio M; Hendricks-Munoz K Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502 [TBL] [Abstract][Full Text] [Related]
35. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Reygrobellet C; Viala-Danten M; Meunier J; Weber F; Nguyen VH Hum Vaccin; 2010 Apr; 6(4):336-45. PubMed ID: 20372083 [TBL] [Abstract][Full Text] [Related]
36. Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 μg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season. Chabanon AL; Bricout H; Ballandras C; Souverain A; Caroe TD; Butler KM Hum Vaccin Immunother; 2018 Feb; 14(2):378-385. PubMed ID: 29148911 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Chi RC; Rock MT; Neuzil KM Clin Infect Dis; 2010 May; 50(10):1331-8. PubMed ID: 20377407 [TBL] [Abstract][Full Text] [Related]
39. Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season. Gandhi-Banga S; Chabanon AL; Eymin C; Caroe T; Butler K; Moureau A Hum Vaccin Immunother; 2019; 15(9):2154-2158. PubMed ID: 30897026 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of an adsorbed trivalent split influenza vaccine administered by intradermal route. Niculescu IT; Zilişteanu E; Alexandrescu V; Maţepiuc M; Creţescu L; Ionescu N; Molnar G; Răcăşan R; Mogoş A Arch Roum Pathol Exp Microbiol; 1981; 40(1):67-70. PubMed ID: 7185350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]